Benign Nerve Sheath Tumor in Dogs (Schwannoma)
- Occurrence: rarer
- Location of disease: General/Whole body, Head/Neck
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
A schwannoma, also known as a peripheral nerve sheath tumor, is a benign tumor that originates from the Schwann cells that form the myelin sheath around peripheral nerves. These tumors can occur in various regions of the body and typically affect the nerves outside the central nervous system (CNS).
Das Wichtigste auf einen Blick
A schwannoma, also known as a peripheral nerve sheath tumor, develops due to abnormal growth of Schwann cells, which are responsible for the myelin sheath of nerves. These tumors are usually benign and do not metastasize, but due to their size they can put pressure on nearby structures and cause symptoms such as Lameness, Muscle weakness, and, less commonly, Paralysis. The exact causes are not fully understood; however, genetic factors and possibly environmental factors or previous injuries also play a role. Diagnosis includes a physical examination and imaging procedures such as X-ray, CT, or MRI, followed by a biopsy for confirmation. Treatment depends on the tumor’s size and location; surgical removal is preferred. Radiation therapy may be considered if the tumor is difficult to access. Chemotherapy is rarely used. The prognosis is usually favorable if the tumor can be completely removed. Despite the low risk of metastasis, quality of life can be affected by tumor symptoms. There are no specific preventive measures, but general health monitoring can help detect problems early. Current research focuses on better diagnostic methods, genetic causes, and new treatment options such as immunotherapy.
Ursachen
Schwann cells are responsible for forming the myelin sheath, which provides protective insulation around nerve fibers and enables the rapid transmission of nerve impulses. Schwannomas arise from the abnormal growth of these cells. They are usually benign, meaning they do not metastasize or spread to other parts of the body. However, due to their size and location, they can exert pressure on adjacent structures, leading to various symptoms.
The exact cause of schwannoma growth is not fully understood. It is believed that genetic factors play a role, particularly mutations in genes that regulate cell growth. A known genetic condition that increases the risk of schwannomas is Neurofibromatosis Type 2 (NF2). In dogs, however, hereditary causes are less clear, and research in this area is still ongoing.
Other possible causes or risk factors could include environmental factors as well as previous injuries or Inflammatory conditions in the affected area. However, there is currently no definitive link between these factors and the formation of schwannomas in dogs.
Symptoms
Symptoms of a schwannoma in dogs can vary significantly depending on the size and location of the tumor. Common signs include lethargy, loss of appetite, and weight loss. If the tumor exerts pressure on nerves, neurological symptoms such as lameness, numbness, or weakness in the affected limbs may occur.
In some cases, depending on its location, a schwannoma can also cause visible Swelling or lumps under the skin. If the tumor occurs in the head or neck area, it can lead to difficulty swallowing or changes in the dog’s voice.
For tumors growing in the abdominal cavity, symptoms such as vomiting, diarrhea, or abdominal pain may occur. These symptoms result from the pressure the tumor exerts on internal organs.
Diagnose
Diagnosing a schwannoma usually begins with a thorough physical examination and a review of the dog’s medical history. The veterinarian will look for signs of neurological deficits and physical changes that could indicate a tumor.
Imaging procedures such as X-ray, ultrasound, CT (computed tomography), or MRI (magnetic resonance imaging) can be used to determine the tumor’s exact location and size. These methods are particularly helpful for assessing whether the tumor is putting pressure on nearby structures.
A biopsy, in which a tissue sample is taken from the tumor and examined under a microscope, is often necessary to confirm the diagnosis. This analysis helps determine whether the tumor is benign or malignant and to plan appropriate treatment.
Therapie
Treatment for a schwannoma in dogs depends on several factors, including the size and location of the tumor, as well as the dog’s overall health. Surgical removal is often the preferred treatment method, especially if the tumor is accessible and does not affect vital structures.
In cases where the tumor cannot be completely removed surgically or if the tumor is in a difficult location, radiation therapy may be considered to control tumor growth and relieve symptoms.
Chemotherapy is used less often for schwannomas because these tumors are usually benign. In some cases, especially if the Tumors are inoperable, drug treatment may be considered to control tumor growth and relieve symptoms.
Prognose und Nachsorge
The prognosis for dogs with a schwannoma largely depends on the tumor’s location and whether it can be completely removed. Schwannomas that can be fully removed and do not involve vital structures generally have a good prognosis.
If the tumor cannot be completely removed, this can increase the risk of regrowth. Follow-up care is crucial to detect possible recurrences early and respond accordingly.
Since schwannomas rarely metastasize, the long-term prognosis is more favorable compared to malignant tumors, although the dog’s quality of life may be affected by the symptoms of the tumor.
Prävention
Because the exact causes of schwannomas in dogs are not fully understood, there are no specific preventive measures to prevent them from occurring. However, general health monitoring and regular veterinary check-ups can help detect and treat health problems early.
A healthy diet, sufficient exercise, and avoiding environmental toxins can support the dog’s overall health and may reduce the risk of developing various Tumors, including schwannomas.
It is also important to watch for signs of neurological or physical changes in dogs and to see a veterinarian promptly if you suspect health problems, to enable early diagnosis and treatment.
At present, there are no specific genetic tests to determine the risk of schwannomas in dogs. However, research in this field could provide new insights in the future, as well as possible prevention strategies.
Ausblick auf aktuelle Forschung
Current research on schwannomas in dogs focuses on improving diagnostic procedures and increasing treatment efficiency. Scientists are exploring advanced imaging techniques such as MRI and CT to determine the exact location and extent of these tumors more precisely. These advances can help veterinarians make more accurate diagnoses and develop individualized treatment plans.
Another area of research focuses on the genetic and molecular basis of schwannomas. Researchers are investigating which genetic changes or mutations promote the growth of these tumors. Such findings could not only lead to better diagnostic methods but also contribute to the development of more targeted therapies aimed at the tumors’ specific genetic profiles.
In therapy development, intensive work is being done to improve surgical methods to remove tumors more effectively and with lower risk for the dog. In addition, alternative treatment strategies are being explored, including combining chemotherapy and radiation therapy to increase the effectiveness of tumor treatment and reduce the risk of recurrence.
Another promising research approach involves immunotherapy. Scientists are investigating how to activate the immune system in dogs to target tumor cells. This could offer a gentler treatment option with fewer side effects than traditional therapies.
In addition to basic research, there are also studies on new medications and their potential benefits in treating schwannomas. Clinical trials are being conducted to evaluate the effectiveness and safety of these new drugs, which could lead to new treatment options in the coming years.
Finally, research also emphasizes the quality of life of affected dogs. Studies evaluate how different treatment approaches influence dogs’ well-being and life expectancy, providing veterinarians and owners with a solid basis for decision-making.
Frequently Asked Questions (FAQs)
1. What is a schwannoma in dogs?
2. What symptoms do dogs with a schwannoma show?
3. How is a schwannoma diagnosed in dogs?
4. Can schwannomas in dogs be malignant?
5. What treatment options are available for dogs with a schwannoma?
6. What is the prognosis for dogs with a schwannoma?
7. Are there preventive measures against schwannomas in dogs?
8. Are certain dog breeds more susceptible to schwannomas?
9. How can I help my dog after schwannoma treatment?
10. How common are schwannomas in dogs?
Literatur
- Cooper-Khan, R. S., Frankovich, A. N., Thompson, C. A., Thomovsky, S. A., & Lewis, M. J. (2024). Clinical findings and outcome in 30 dogs with presumptive or confirmed nerve sheath tumors. Veterinary Sciences, 11(5), 192. https://doi.org/10.3390/vetsci11050192
- Deacon, J., Bongers, J., & Stalin, C. (2025). Canine spinal peripheral nerve sheath tumours in 18 dogs (2014–2023): Surgical management and long-term outcomes. Frontiers in Veterinary Science, 12, 1653812. https://doi.org/10.3389/fvets.2025.1653812
- Tekavec, K., Švara, T., Knific, T., Gombač, M., & Cantile, C. (2022). Histopathological and immunohistochemical evaluation of canine nerve sheath tumors and proposal for an updated classification. Veterinary Sciences, 9(5), 204. https://doi.org/10.3390/vetsci9050204
- Chijiwa, K., Uchida, K., & Tateyama, S. (2004). Immunohistochemical evaluation of canine peripheral nerve sheath tumors and other soft tissue sarcomas. Veterinary Pathology, 41(4), 307–318. https://doi.org/10.1354/vp.41-4-307
- Gaitero, L., Añor, S., Fondevila, D., & Pumarola, M. (2008). Canine cutaneous spindle cell tumours with features of peripheral nerve sheath tumours: A histopathological and immunohistochemical study. Journal of Comparative Pathology, 139(1), 16–23. https://doi.org/10.1016/j.jcpa.2008.03.003
- Hansen, K. S., Zwingenberger, A. L., Théon, A. P., Pfeiffer, I., & Kent, M. S. (2016). Treatment of MRI-diagnosed trigeminal peripheral nerve sheath tumors by stereotactic radiotherapy in dogs. Journal of Veterinary Internal Medicine, 30(4), 1112–1120. https://doi.org/10.1111/jvim.13970
- Brehm, D. M., Vite, C. H., Steinberg, H., Haviland, J., & van Winkle, T. (1995). A retrospective evaluation of 51 cases of peripheral nerve sheath tumors in the dog. Journal of the American Animal Hospital Association, 31(4), 349–359. https://doi.org/10.5326/15473317-31-4-349